Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Pharmaceutical industry · Guangzhou, Guangdong
About Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. is a Chinese high-tech pharmaceutical company based in Guangzhou, Guangdong Province, belonging to the Guangzhou Baiyunshan Pharmaceutical group and to Guangyao Group (GPHL), of which it is one of around 30 member companies. Its origins date back to 2001, when its predecessor devoted to traditional Chinese medicine research was established, and it adopted its current name in 2012.
Its speciality is the production of distinctive pharmaceutical active ingredients, excipients and pharmaceutical lipid raw materials — including phospholipids and products such as medium-chain triglycerides and refined olive oil, approved for marketing in 2022-2023 — together with functional foods and healthy nutrition products. It also provides technical services in traditional Chinese medicine extraction and separation, pilot scale-up, industrial validation and quality control using online near-infrared spectroscopy.
The company hosts the Guangdong Provincial and Guangzhou Municipal Key Laboratory of Pharmaceutical Lipids and several provincial and municipal engineering and technology centres, has registered products with the US FDA, and was recognized in 2024 as a national specialized 'little giant' enterprise and a National Green Factory. Its own official website, with a Spanish-language version, is distinct from its parent group's site and presents its profile, history, team — including 11 PhDs and National Pharmacopoeia experts — and its direct contact telephone.
Its speciality is the production of distinctive pharmaceutical active ingredients, excipients and pharmaceutical lipid raw materials — including phospholipids and products such as medium-chain triglycerides and refined olive oil, approved for marketing in 2022-2023 — together with functional foods and healthy nutrition products. It also provides technical services in traditional Chinese medicine extraction and separation, pilot scale-up, industrial validation and quality control using online near-infrared spectroscopy.
The company hosts the Guangdong Provincial and Guangzhou Municipal Key Laboratory of Pharmaceutical Lipids and several provincial and municipal engineering and technology centres, has registered products with the US FDA, and was recognized in 2024 as a national specialized 'little giant' enterprise and a National Green Factory. Its own official website, with a Spanish-language version, is distinct from its parent group's site and presents its profile, history, team — including 11 PhDs and National Pharmacopoeia experts — and its direct contact telephone.